SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001585364-24-000027
Filing Date
2024-03-07
Accepted
2024-03-07 21:47:43
Documents
3
Period of Report
2023-11-16

Document Format Files

Seq Description Document Type Size
1 FORM 4/A wk-form4a_1709866052.html 4/A  
1 FORM 4/A wk-form4a_1709866052.xml 4/A 3391
2 EX-24 a05_25x2022xivesxpoaxfor.htm EX-24 3496
3 GRAPHIC a05_25x2022xivesxpoaxfor001.jpg GRAPHIC 232742
  Complete submission text file 0001585364-24-000027.txt   329113
Mailing Address 515 EASTERN AVENUE ALLEGAN MI 49010
Business Address THE SHARP BUILDING HOGAN PLACE DUBLIN 2 L2 D02 TY74 269-673-8451
PERRIGO Co plc (Issuer) CIK: 0001585364 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PERRIGO COMPANY PLC 515 EASTERN AVENUE ALLEGAN MI 49010
Business Address
Ives Alison (Reporting) CIK: 0001932375 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36353 | Film No.: 24732195